25
Mar
Mar
Surveyed Experts Indicate That Byetta LAR And Victoza Have Advantages Over Actos In The Treatment Of Type 2 Diabetes
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and health care issues, finds that surveyed endocrinologists indicate that a therapy’s effect on glycosylated hemoglobin A1c (HbA1c) is the attribute that most influences their prescribing decisions in Type Two Diabetes.
